“…Over the last years, research interest in binase is constantly being increased because of selective cytotoxicity of this enzyme toward certain cancer cells. Binase inhibits proliferation of human leukemic Kasumi-1 cells, lung adenocarcinoma cells, ovarian and breast cancer cells ( Mitkevich et al, 2011 ; Cabrera-Fuentes et al, 2013 ; Garipov et al, 2014 ; Zelenikchin et al, 2016 ). The sensitivity of cancer cells to binase toxic action depends on the expression of ras, kit , AML1-ETO and FLT3 oncogenes, but does not depend on the expression of fms and src oncogenes ( Ilinskaya et al, 2001 , 2016 ; Mitkevich et al, 2011 , 2013b ).…”